---
title: "Hong Kong Stock Market Closing (09.05) | Hang Seng Index rose by 1.43%, new energy sector surged, and non-ferrous metals and pharmaceutical stocks regained upward momentum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256089752.md"
description: "Hong Kong stocks rebounded strongly today, with the Hang Seng Index closing up 1.43% at 25,417.98 points, with a turnover of HKD 299.945 billion. The market is focused on the U.S. non-farm payroll data to be released tonight, increasing the possibility of foreign capital inflow. Blue-chip stocks performed strongly, with XINYI SOLAR rising 7.54% and SINO BIOPHARM rising 6.2%. In the medium to long term, the outlook for Hong Kong stocks is positive, with sufficient momentum for short-term catch-up, and it is expected to continue a slow bull market with fluctuations upward"
datetime: "2025-09-05T08:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256089752.md)
  - [en](https://longbridge.com/en/news/256089752.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256089752.md)
generator: "portal-rs"
---

# Hong Kong Stock Market Closing (09.05) | Hang Seng Index rose by 1.43%, new energy sector surged, and non-ferrous metals and pharmaceutical stocks regained upward momentum

According to Zhitong Finance APP, the market is focused on the U.S. non-farm payroll data to be released tonight. The Hong Kong stock market today swept away its previous downturn, with the three major indices rebounding strongly, and the Hang Seng Index at one point rising over 2% in the closing hours. By the end of trading, the Hang Seng Index rose 1.43% or 359.47 points, closing at 25,417.98 points, with a total turnover of HKD 29.9945 billion; the Hang Seng China Enterprises Index rose 1.34%, closing at 9,057.22 points; the Hang Seng Tech Index rose 1.95%, closing at 5,687.45 points. For the week, the Hang Seng Index accumulated a rise of 1.36%, the China Enterprises Index accumulated a rise of 1.22%, and the Hang Seng Tech Index accumulated a rise of 0.23%.

The Cathay Pacific Haitong Overseas Strategy Team pointed out that under the Federal Reserve's resumption of interest rate cuts, there is a possibility of an unexpected return of foreign capital to the Hong Kong stock market. From a stock perspective, foreign capital in Hong Kong particularly favors technology and finance. Industrial Securities stated that in the medium to long term, they are firmly bullish on Hong Kong stocks, and in the short term, there is sufficient momentum for Hong Kong stocks to catch up, driven by the revaluation of the Hang Seng Tech Index and global capital allocation demand, which is expected to continue a slow bull market with fluctuations upward.

## **Blue Chip Performance**

XINYI SOLAR (00968) led the blue chips. By the end of trading, it rose 7.54%, closing at HKD 3.71, with a turnover of HKD 1.023 billion, contributing 1.89 points to the Hang Seng Index. The Ministry of Industry and Information Technology and the State Administration for Market Regulation recently issued an action plan, pointing out the need to legally govern low-price competition in photovoltaic and other products. They guide localities to orderly layout the photovoltaic and lithium battery industries and assist localities in sorting out production capacity. Zhongyuan Securities believes that the valuation level of the photovoltaic industry is at a historical low, and under the background of reversing involution, there is an opportunity for valuation recovery in the industry.

In other blue chip stocks, SINO BIOPHARM (01177) rose 6.2%, closing at HKD 8.91, contributing 8.54 points to the Hang Seng Index; Hang Lung Properties (00101) rose 6.13%, closing at HKD 8.49, contributing 1.53 points to the Hang Seng Index; New Oriental-S (09901) fell 1.52%, closing at HKD 37.66, dragging down the Hang Seng Index by 0.68 points; Budweiser APAC (01876) fell 1.41%, closing at HKD 8.41, dragging down the Hang Seng Index by 0.39 points.

## **Popular Sectors**

On the market, large technology stocks collectively rose, with Kuaishou rising over 4%, Tencent rising over 2%, and JD, Meituan, and Alibaba all rising over 1%. Multiple favorable catalysts led to a surge in new energy sectors such as solid-state batteries, photovoltaics, wind power, and energy storage, with many stocks rising over 10%; the innovative drug concept regained momentum today, with 3SBio soaring over 18% to a new high, and Hengrui Medicine's BD transactions adding new orders, with the stock price rising nearly 6%; expectations for U.S. interest rate cuts continue to heat up, leading to a collective rise in gold stocks; chip stocks, paper industry stocks, Apple concept stocks, and robotics concept stocks all performed well.

**1\. New energy sectors such as photovoltaics and energy storage have exploded.** By the end of trading, Zhongchuang 航 (03931) rose 18.37%, closing at HKD 29.26; Xinte Energy (01799) rose 17.28%, closing at HKD 8.89; Longpan Technology (02465) rose 13%, closing at HKD 10.17; GCL-Poly Energy (03800) rose 12.21%, closing at HKD 1.47.

On September 4, the Ministry of Industry and Information Technology and the State Administration for Market Regulation issued the "2025-2026 Stable Growth Action Plan for the Electronic Information Manufacturing Industry," which clearly states that high-quality development in fields such as photovoltaics should be achieved by breaking down "involution-style" competition and legally governing low-price competition in photovoltaic and other products Guide local orderly layout of photovoltaic and lithium battery industries, and instruct localities to sort out production capacity. The "Action Plan" also points out the need to enhance collaborative research efficiency and support basic research in cutting-edge technology directions such as artificial intelligence, advanced storage, three-dimensional heterogeneous integrated chips, and all-solid-state batteries.

In terms of energy storage, according to feedback from the industry chain, leading lithium battery cell companies have full production lines for energy storage, and prices for some energy storage cells have begun to rise. Some analyses indicate that the lithium battery industry has entered the traditional peak season, with a significant increase in production scheduling across the industry chain. Independent energy storage has shown explosive growth after policy optimization, with an annual year-on-year growth rate expected to approach 30%; in addition, global AI construction is accelerating, leading to a surge in demand for AIDC data center support, significantly raising the requirements for power systems and liquid cooling technology; at the same time, the solid-state battery industry is progressing beyond expectations, with a substantial increase in orders from equipment manufacturers and a continuous acceleration of the industrialization process.

**2\. The innovative drug concept makes a comeback.** As of the close, 3SBio Inc. (01530) rose 18.24% to HKD 35.66; CanSino Biologics-B (02162) rose 14.53% to HKD 78.45; Kingsoft Cloud Holdings (02228) rose 12.18% to HKD 10.68; and Shanghai Pharmaceuticals Holding (02005) rose 9.8% to HKD 3.25.

The 2025 World Lung Cancer Conference (WCLC) will be held from September 6 to 9, with 35 oral presentations from Chinese scholars. In addition, Heng Rui Medicine has added a new BD transaction, announcing this morning a more than USD 1 billion overseas BD transaction based on the drug for hypertrophic cardiomyopathy (HRS-1893), with the counterparty being the American company Braveheart Bio, which includes an upfront payment of USD 65 million. It is worth mentioning that since the beginning of this year, domestic innovative drugs have achieved 83 external licensing agreements, involving a total amount of USD 84.531 billion, a significant increase of 73.2% compared to the total of USD 48.813 billion for the entire year of 2024. The global proportion of external licensing transaction amounts has rapidly increased from less than 1% in 2019 to 51.73% so far this year.

**3\. Gold stocks collectively rise.** As of the close, Shandong Gold (01787) rose 5.87% to HKD 32.82; Zijin Mining (02899) rose 5.85% to HKD 28.24; Zhaojin Mining (01818) rose 4.44% to HKD 28.24; and China Gold International (02099) rose 4.06% to HKD 120.6.

On the evening of September 4, ADP data showed that U.S. ADP employment increased by 54,000 in August, lower than market expectations. According to the latest data from the U.S. Department of Labor, the number of initial jobless claims in the week ending August 30 was 237,000, higher than market expectations. The continued cooling of the U.S. labor market further strengthens expectations for a Federal Reserve interest rate cut, with current market pricing showing a 97.4% probability of a rate cut in September. Following the release of ADP data, the market is focused on the U.S. non-farm payroll data to be released on Friday. Additionally, Goldman Sachs predicts that if the Federal Reserve's credibility is damaged, gold prices could rise to nearly USD 5,000 per ounce; Goldman Sachs recommends long-term investment in gold as a means of preserving value that is not affected by institutional trust **4\. Chip stocks rebounded today.** As of the close, InnoCare (02577) rose 8.52% to HKD 99.35; Jingmen Semiconductor (02878) rose 5.62% to HKD 0.47; SMIC (00981) rose 4.82% to HKD 58.7; Hua Hong Semiconductor (01347) rose 4.16% to HKD 47.58.

The Ministry of Industry and Information Technology and the State Administration for Market Regulation issued the "Action Plan for Stable Growth in the Electronic Information Manufacturing Industry 2025-2026." It proposed to strengthen efforts in key areas such as CPU, high-performance artificial intelligence servers, and software-hardware collaboration, and to conduct adaptability testing for artificial intelligence chips and large models; encourage localities to promote innovative applications of artificial intelligence terminals, and push for technological breakthroughs in key components, chips, and modules for 5G/6G. The plan also pointed out the unwavering promotion of "domestic goods for domestic use," increasing policy support for key enterprises in the industrial chain. Donghai Securities believes that industry demand is slowly recovering, prices are warming up; under overseas pressure, the strength of self-control is still increasing, and it is advisable to gradually layout at low points.

## **Popular Active Stocks**

**1\. Tianyue Advanced (02631) reached a new high, closing up 18.24% at HKD 49.78.**

According to the Science and Technology Innovation Board Daily, to enhance performance, NVIDIA plans to replace the intermediate substrate material in the development blueprint of the new generation Rubin processor from silicon to silicon carbide (SiC) in the advanced packaging stage of CoWoS. It is reported that Tianyue Advanced has made early arrangements in the silicon carbide substrate product matrix. Currently, the group has formed a matrix of 6/8/12-inch silicon carbide substrate products, including 12-inch high-purity semi-insulating silicon carbide substrates, 12-inch conductive P-type, and 12-inch conductive N-type silicon carbide substrates.

**2\. Goldwind Technology (02208) surged significantly, closing up 18.06% at HKD 10.46.**

In the first half of this year, Goldwind Technology achieved revenue of RMB 28.494 billion, a year-on-year increase of 41.46%; the profit attributable to shareholders was RMB 1.488 billion, a year-on-year increase of 7.26%. Everbright Securities pointed out that the company's wind turbine quality and after-service capabilities remain industry-leading, with continuous improvement in wind turbine profitability, and the increase in order scale is expected to steadily boost the company's market share, maintaining a "buy" rating for the company's A/H shares.

**3\. Chow Tai Fook (06168) remained strong throughout the day, closing up 16.58% at HKD 50.2.**

Recently, gold prices have been running high, coupled with the traditional consumption peak season of "golden September and silver October," attracting attention to the gold consumption market. CITIC Securities research report indicates that in the short term, with gold prices stabilizing in Q3 2025 and a low base, gold jewelry sales may perform well. In addition, the Hang Seng Index Company previously announced that Chow Tai Fook was included in the Hang Seng Composite Index, with changes to be implemented after the market closes on September 5 and effective from September 8 **4\. Huilyang Technology (01860) hits a new high again, closing up 9% at HKD 18.16.**

According to a research report from Kaiyuan Securities, the company's revenue surged in the first half of the year, and its net profit margin significantly improved. The substantial growth in performance is mainly attributed to the continuous iteration of the AI-driven intelligent bidding system, the strengthening of the company's flywheel effect, and the further emergence of scale effects. Based on the company's intelligent bidding system expansion and the development of non-gaming verticals, the firm has raised its profit forecasts for 2025-2026 and added a new forecast for 2027. They are optimistic about Mintegral's continued contribution to revenue growth.

**5\. Zhongshen Jianye (02503) plummets on increased volume, closing down 72.36% at HKD 0.55.**

Public information shows that Zhongshen Jianye is the first construction general contracting company listed on the main board of the Hong Kong Stock Exchange in the Guangdong-Hong Kong-Macao Greater Bay Area. The company previously released its 2025 semi-annual report, indicating that revenue for the period was HKD 201 million, a decrease of 46.9% year-on-year, with a loss attributable to shareholders of HKD 11.81 million, compared to a profit of HKD 335,000 in the same period last year, marking a shift from profit to loss in the semi-annual report

### Related Stocks

- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [00968.HK](https://longbridge.com/en/quote/00968.HK.md)

## Related News & Research

- [Sino Biopharma reports Phase I data showing TQC3721 dry powder inhaler boosts COPD lung function in dose-ranging trial](https://longbridge.com/en/news/298202928.md)
- [Sino Biopharm presents ERS 2026 preclinical data for oral STAT6 degrader TQH5528](https://longbridge.com/en/news/298295965.md)
- [Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumors](https://longbridge.com/en/news/297915540.md)
- [Sino Biopharm CEO Tse says AI, internationalization anchor counter-cyclical growth strategy](https://longbridge.com/en/news/298258012.md)
- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**